TIGIT blockade enhances tumor response to radiotherapy via a CD103 + dendritic cell-dependent mechanism

Blockade of the T cell immunoreceptor with the immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain (TIGIT) can enhance innate and adaptive tumor immunity and radiotherapy (RT) can enhance anti-tumor immunity. However, our data suggest that TIGIT-mediated immune suppression may b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Kaikai, Jiang, Liyang, Si, Youjiao, Zhou, Shujie, Huang, Zhaoqin, Meng, Xiangjiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813151/
https://www.ncbi.nlm.nih.gov/pubmed/35794399
http://dx.doi.org/10.1007/s00262-022-03227-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813151/
https://www.ncbi.nlm.nih.gov/pubmed/35794399
http://dx.doi.org/10.1007/s00262-022-03227-z

Ejemplares similares